November 2005
An open letter to chiropractors
by Bob Blanks, PhD, RCS President
I would like to take
this opportunity to fill you in on the progress of the past six months, and
to tell you about several new and exciting projects to be coordinated by
Research & Clinical Science (RCS).
IRB approval and
electronic data repository: As
you know, RCS is an Electronic Chiropractic Record (ECR) company. Full IRB
approval has been obtained to create an interactive electronic data
repository to track all patient data from participating chiropractic
offices. Note that we will be collecting health outcomes data from
chiropractic offices worldwide. This international study may seem large but
is necessary to control for the thousands of patient sociodemographic,
clinical and other outcome measures.
The system will
accommodate data from chiropractors practicing up to 65 different techniques
and using any variety of outcome measures (e.g., X‑rays, surface EMG, etc.).
The electronic data capture network is HIPAA compliant, and protects patient
privacy by using custom software to redact all patient identifiers. Once the
data sets are complete they will be made available to any group requesting
the information for research purposes, and to members of our scientific
panel for their research. The long‑term objective is to promote
evidence‑based chiropractic.
The RCS network will
create the largest data repository in chiropractic‑ think of it as a
practice‑based "Framingham" study.
Training sessions
for participating data collection sites:
These RCS training sessions cover all required training for research
participants (human subjects consent, electronic data capture, data entry,
compliance, etc.) in an intense 14‑hour weekend course. Clearly, a
multi‑center clinical study of this scope requires tremendous coordination,
but we have a great team of individuals experienced in conducting health
outcomes studies of this type and others who are well‑connected in the field
of chiropractic.
First RCS
International Scientific Advisory Panel and Research Symposia:
As part of our first International Scientific Board Meeting, we have
arranged a mini‑conference to be held in Washington
DC, Saturday May 5‑6 in conjunction
with the annual World Chiropractic Alliance (WCA) Summit Meetings. I
arranged to have some members of our scientific panel speak about their
research objectives focusing upon a central theme of "Early Biomarkers for
Disease Prevention and Health Promotion." I have scheduled a one‑hour panel
discussion, allowing all members of the Panel to address specific questions
on brain diseases, child health, elder care, allergic asthma, growth factors
and stem cell research, osteology etc.
Future research:
RCS will rely heavily on the International Scientific Advisory Panel to
provide direction for the next phase of research. Once the current
"characterization phase" has been completed, RCS will be able to initiate
several clinical trials and other research formats to evaluate chiropractic
in relation to general health measures or specific health conditions. RCS
will rely on the advise of the ISAP for topic areas, research design, and
outcome measures for clinical research, and the types of experiments
required for hypothesis driven research underlying the mechanisms of
mind‑body communication in chiropractic.
Challenges to
working within the profession:
Finally, some of you will be aware that there are several major factions
within the field of chiropractic. As I understand it, one faction wants to
align with medicine and focus on musculoskeletal (low back) pain relief,
whereas the other follows the original tenants of chiropractic as a system
of care with potential applications across many body systems. These two
factions sometimes bring criticism from the biomedical community and from
within chiropractic itself. RCS has made it clear that we will work with any
and all members of the profession who value scientific, evidenced‑based
research because this is our goal. We are conducting legitimate IRB‑approved
health outcomes research and we have nothing to hide from those with
political agendas. Frankly, as chair of a medical IRB at UCI for many years,
the factions in chiropractic almost seem minor compared to some of the hotly
contested issues in biomedicine and some of the sponsor‑driven protocols
from the pharmaceutical industry.
RCS has launched a
major health outcomes research program that will produce much valuable
information that should benefit the population, health education, research
and hopefully produce sufficient peer‑reviewed research to favorable impact
health policy reform.
(Dr. Blanks is
Professor in the Department of Biomedical Sciences at Florida Atlantic
University and a past Professor of Anatomy and Neurobiology at the
University of California, Irvine. Prior to this he spent two years at the
Max Planck Institute for Brain Research in Frankfurt, Germany and two years
in the Department of Anatomy at Harvard Medical School. Dr. Blanks is on the
Advisory Board of the International Spinal Health Institute, is a Board
Member of the Council on Chiropractic Practice and is actively involved in
chiropractic research.)